| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497262A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1496947A1 Removal of adenine during a process of pathogen reducing blood and blood components |
| 01/19/2005 | EP1496936A1 Intraventricular hemorrhage thrombolysis |
| 01/19/2005 | EP1496926A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496905A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496884A1 Association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/19/2005 | EP1496877A2 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 01/19/2005 | EP1496873A2 Chewable soft capsule |
| 01/19/2005 | EP1287018B1 Thrombin inhibitors |
| 01/19/2005 | EP1200385B1 Crystals of the sodium salt of pravastatin |
| 01/19/2005 | EP1140038B1 Transdermal drug delivery system |
| 01/19/2005 | CN1568307A Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568206A Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leuko-filter |
| 01/19/2005 | CN1568198A Use of cd23 antagonists for the treatment of neoplastic disorders |
| 01/19/2005 | CN1568181A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/19/2005 | CN1566356A Method for preparing earthworm bioactive peptide and earthworm biological micro-fertilizer and use thereof |
| 01/19/2005 | CN1565622A Therapeutic agent to recover hematopoiesis function and its compositions and usage |
| 01/19/2005 | CN1565619A Novel usage of soluble P-lectin and anthrax lethal toxin |
| 01/19/2005 | CN1565599A Chinese drug injection formulation for dissolving cerebral thrombus |
| 01/19/2005 | CN1565577A Medicinal capsule of rhubarb horsetails and granule beetle and its preparation method |
| 01/19/2005 | CN1565571A Pharmaceutical composition for treating idiopathic thrombocytopenic purpura of blood heat type and its preparing process |
| 01/19/2005 | CN1565488A Kidney tonifying |
| 01/19/2005 | CN1565486A Leucocyte increasing pills and its preparation method |
| 01/19/2005 | CN1565483A Medicine for treating chronic and refractory primary thrombocytopenic purpura |
| 01/19/2005 | CN1565474A Biochemical nucleic acid fulvic acid oral liquid production method |
| 01/19/2005 | CN1565472A Breviscapine slow release microsphere medicine formulation |
| 01/19/2005 | CN1565471A Breviscapine drop pill |
| 01/19/2005 | CN1565465A Injection preparation containing breviscapine active component and its preparation method |
| 01/19/2005 | CN1185352C Compounds having glucuronic acid derivatives and glucosamine derivatives in structure, process for producing same and utilization thereof |
| 01/19/2005 | CN1185344C Protein for blocking platelet adhesion |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/19/2005 | CN1185010C Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 01/19/2005 | CN1185008C Therapeutic compositions containing glutathione analogs |
| 01/19/2005 | CN1184973C Thrombolytic leech soft capsule and its preparing method |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844348 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844345 Piperazine derivatives |
| 01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6844317 Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/16/2005 | WO2005000281A2 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/16/2005 | CA2529436A1 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/13/2005 | WO2005003347A2 Dna-based aptamers for human cathepsin g |
| 01/13/2005 | WO2005003138A2 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
| 01/13/2005 | WO2005002617A2 Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases |
| 01/13/2005 | WO2005002574A1 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/13/2005 | WO2004082567A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2004006958A8 Stable pharmaceutical composition comprising erythropoietin |
| 01/13/2005 | WO2003089569A3 Use of il-19, il-22 and il-24 to treat hematopoietic disorders |
| 01/13/2005 | WO2003084922A8 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009914 Increasing the production of the blood-forming hormone erythropoietin, especially for the treatment of aging- or disease-related conditions associated with decreased oxygen supply to the tissue, especially in elderly subjects, in the treatment of malignant diseases and in cardiorespiratory disorders |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009872 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050009736 Administering by hemodilution an aqueous cell-free polyalkylene oxide surface modified hemoglobin without intramolecular crosslinking; oxygen affinity greater than whole blood; blood disorders |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009024 Using allelic variance in carboxypeptidase gene as diagnostic indicator of cardiovascular disease |
| 01/13/2005 | US20050008655 Useful as barrier applied to skin; chemical and radiation resistance; skin disorders; autoimmune diseases; antitumor agents; topical applying |
| 01/13/2005 | US20050008654 For prevention, therapy of sepsis shock, thrombosis disorders |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | CA2531360A1 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 01/13/2005 | CA2530480A1 Conjugated complement cascade inhibitors |
| 01/13/2005 | CA2530446A1 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
| 01/13/2005 | CA2528686A1 Dna-based aptamers for human cathepsin g |
| 01/12/2005 | EP1495763A1 Therapeutic cream for dermatitis |
| 01/12/2005 | EP1495762A1 Therapeutic lotion for dermatitis |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495111A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 01/12/2005 | EP1495052A1 Modified factor viii |
| 01/12/2005 | EP1495051A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495030A1 Non-steroidal progesterone receptor modulators |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495018A1 Tricyclic thrombin receptor antagonists |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494999A1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |